does tirzepatide cause kidney issues Long-Term Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF Tirzepatide and prevention of chronic

Mitigate cancer risks Semaglutide has the potential to lower the likelihood of certain types of cancer

In the SURPASS-4 trial, 15 mg weekly tirzepatide reduced the levels of total cholesterol, LDL cholesterol, and triglycerides by 5.6%, 7.9%, and 22.5%, respectively, and increased the levels of good cholesterol -HDL by 10.8% compared to placebo

A 180-pound person would lose roughly 40 pounds

Same eligibility criteria, same follow-up duration

The clinical trials this warning is based on were done on rats that had been given very large doses of a GLP-1 drug, not in humans

If you take diabetes meds, watch for hypoglycemia when GLP-1 or GIP agents add glucose-lowering effect